期刊文献+

蛋氨酸脑啡肽(MEK)联合干扰素γ抗肿瘤作用研究 被引量:8

Anti-Tumor Effect of Methionine Enkephalin in Combination with Interferon-γ
下载PDF
导出
摘要 观察蛋氨酸脑啡肽(MEK)和注射用重组人干扰素γ(IFN-γ)单独和联合应用的抗肿瘤效应。应用动物移植性肿瘤的体内试验法,分别观察MEK、IFN-γ和MEK+IFN-γ对肿瘤的抑瘤作用及小鼠生命延长率情况。结果显示,MEK组、IFN-γ组和MEK+IFN-γ组的抑瘤作用分别为129.11%(P<0.001)、78.11%(P<0.001)、231.10%(P<0.001),均有显著差异;生命延长率MEK组20.28%(P<0.001)有显著差异,IFN-γ组13.50%(P>0.001)无显著差异,MEK+IFN-γ组41.25%(P<0.001)有显著差异。可见,MEK、IFN-γ和MEK+IFN-γ都对小鼠移植性瘤有一定的抑制作用,MEK和MEK+IFN-γ能够延长小鼠生命,而IFN-γ单独应用不能延长小鼠生命。MEK和IFN-γ联合应用时作用相加。而不良反应未相加。 In order to evaluate the anti-tumor effects of methionine enkephalin (MEK) alone and combined with interferon-γ (IFN-γ) in vivo implanted tumor in mice was used to observe the tumor inhibition rate and survival rate. The results showed that the effect of tumor inhibition rate of MEK group, IFN-γ group, and MEK + IFN-γ were 129.11% ( P 〈0. 001 ), 78.11% (P 〈0. 001 ), and 231.10% (P 〈0. 001 ) respectively, all were significant. And life prolongation of MEK group, IFN-γ group, and MEK + IFN-γ were 20.28% (P 〈 0. 001 ) , significant;13.50% (P 〉0. 001 ) , insignificant; and 41.25% (P 〈 0. 001 ), significant. Therefore, MEK, IFN-γ, and MEK + IFN-γ had a certain inhibition against mice implanted tumor; MEK and MEK + IFN-γ, could prolong the life of mice; while apply IFN-γ alone could not prolong the life. When combine MEK with IFN-γ showed a synergistic effects without side effect observable.
出处 《微生物学杂志》 CAS CSCD 2009年第1期107-109,共3页 Journal of Microbiology
基金 辽宁省自然科学基金(20072086)
关键词 蛋氨酸脑啡肽 注射用重组人干扰素γ 小鼠 抗肿瘤作用 methionine enkephalin (MEK) recombinant human interferonγ mice anti-tumor effect
  • 相关文献

参考文献4

  • 1KOWALSKI J, MAKOWIECKA K,BELOWSKI D, et al. Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages[J]. Neuropeptides, 2000, 34(3/4): 187-92.
  • 2TAKEBA Y, SUZUKI N, KANEKO A, et al. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis [J]. Rheumatol, 2001, 28 (10): 2 176-83.
  • 3侯相山,王洪水.干扰素研究进展[J].安徽农业科学,2007,35(6):1700-1702. 被引量:9
  • 4张领兵 ,朱迅 .蛋氨酸脑啡肽研究进展及其应用前景[J].国外医学(免疫学分册),2005,28(6):354-357. 被引量:15

二级参考文献18

  • 1龚国忠 郑宣鹤 等.Ib型丙肝病毒在外周血单核细胞感染状态及其对IFN应答的影响[J].中华微生物和免疫,1998,18(6):452-454.
  • 2杨华.猪白细胞干扰素治疗小鹅瘟效果观察[J].中国兽医杂志,2000,(2):54-54.
  • 3XU DZ,HUANG K L,ZHAO K,et al.Vaccination with recombinant HBsAg-HBIG complex in healthy adults[J].Vaccine,2005,23(20):2658-2664.
  • 4杜念兴.兽医免疫学[M].2版.北京:中国农业出版社,2000:75-76.
  • 5KEATING G M,PLOSKER G L.Peginterferon alpha-2a(40 kD) plus ribavirin:a review of its use in the management of patients with chronic hepatitis C and persistently ‘normal' ALT levels[J].Drugs,2005,65(4):5211.
  • 6PATRICK MARCELLIN,GEORGE K K LAU,FERRUCCIO BONINO,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-Negative chronic hepatitis B[J].N Engl J Med,2004,351(12):12061.
  • 7杨汉春.动物免疫学[M].2版:北京:中国农业出版社,2004:98.
  • 8MARELLI A,NARDECCHIA L,DEGENNARO F,et al.Therapy of chronic hepatitis C with alphar interferon in 182 patients.evaluation of results,response predictive factors and side effects[J].Minerva Med,1999,90(11/12):405-412.
  • 9COOKSLEY W G,PIRATVISUTH T,LEE SD,et al.Peginterferon alpha-2a(40 kDa):an advance in the treatment of hepatitis Be antigen-positive chronic hepatitis B[J].J Viral Hepat,2003,10(4):2981.
  • 10LAU G,PRIATVISUTH T,KANG X L,et al.Peginterferon alfa-2a(40 kD)(pegasys) monotherapy and in combination with lamivudine is more effective than lamivudine monotherapy in HBeAg-positive chronic hepatitis B:results from a large,multinational study[J].Hepatology,2004,40(S1):1711.

共引文献22

同被引文献132

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部